SPOTLIGHT -
Dr. Chari on the Role of MRD Testing in Multiple Myeloma
Ajai Chari, MD, discusses recommendations for minimal residual disease testing in patients with multiple myeloma.
Read More
Community Advice: SQ Formulation of Daratumumab
Real-World Experience With SQ Monoclonal Antibodies
Study Overview: COLUMBA and PLEIADES
Infusion-Related Adverse Events
Medication Supplements Prior to IV Administration
Intravenous Administration and Hepatitis
The Intravenous Administration of Monoclonal Antibodies
Second-Line Treatment of R/R LBCL With Lisocabtagene Maraleucel (Liso-cel)
ZUMA-7: Axicabtagene Ciloleucel as a Second-Line Therapy for LBCL
Currently Available Treatment Options for Patients With R/R DLBCL
Overview of Relapsed/Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL)